Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Concurrence

Explore full profile

Clinical AI agents for healthcare that extend care teams across patient intake, triage and 24/7 support

New York City, United StatesFounded 2023Health
Valuation $25–50M Last recorded · 2026
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Concurrence and the history behind them.

About Concurrence

Concurrence (formerly Amigo) is a clinical AI infrastructure company for healthcare, building and training AI agents that handle patient-facing clinical workflows — from intake and triage to 24/7 care navigation and post-visit support. Its proprietary “digital residency” model trains each agent across millions of simulated patient scenarios specific to a practice's population, reaching a 100% safety pass rate before real-patient interaction. The platform has logged over 3 million autonomous patient encounters with zero safety incidents and integrates natively with major EHR systems including Epic, Oracle Health and Athenahealth across more than 100 languages. Concurrence provides a shared healthcare data foundation (the “Health World Model”) with configured agent workflows, supervision and outcome evaluation, letting healthcare organizations extend their care teams without adding headcount. SOC 2 Type II, HIPAA, PIPEDA and PHIPA compliant. Backed by Madrona, Optum Ventures, General Catalyst and GSV Ventures, with $17M raised to date.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2023
Headquarters
New York City, United States
Employees
83
Open positions
22
Dealroom signal
76.8/100
Industry
Health, Enterprise Software
Sector
Health, Core AI, AI Agents
Technology
Artificial Intelligence
Business model
SaaS
Client focus
b2c

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Mar 2026 $11M $44M General Catalyst · Optum Ventures · GSV · Madrona Venture Group ↗
SEED✓Equity / VC Sep 2025 — — General Catalyst · GSV ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Concurrence website traffic

Latest recorded traffic for Concurrence is 51K monthly website visits, up 96.2% over the last three months.

Latest monthly visits51K 3-month web change+96.2%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

Series A2 investors entered at this stage

Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
6 countries with
team presence
🇺🇸 United States79.5%
🇮🇳 India9.1%
🇸🇦 Saudi Arabia4.5%
🇦🇷 Argentina2.3%
🇨🇦 Canada2.3%
Top 5 of 6 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Concurrence on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Concurrence’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.